NASDAQ:PPH VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News → I’m a Crypto Millionaire. Here’s Why I Sold ALL My Bitcoin… (From Paradigm Press) (Ad) Free PPH Stock Alerts $92.25 +0.13 (+0.14%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range$91.93▼$92.5350-Day Range$84.87▼$92.1252-Week Range$74.05▼$92.53Volume118,020 shsAverage Volume139,959 shsMarket Capitalization$547.97 millionAssets Under Management$611.31 millionDividend Yield1.69%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get VanEck Pharmaceutical ETF alerts: Email Address About VanEck Pharmaceutical ETF (NASDAQ:PPH)The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.Read More PPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PPH ETF News HeadlinesMay 8, 2024 | msn.comJust Say No to Drugs: 3 Pharma Stocks to AvoidApril 23, 2024 | seekingalpha.comPPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total ReturnsApril 18, 2024 | theglobeandmail.comCanada’s updated guidance on ESG-related investment fund disclosureApril 3, 2024 | msn.comVanEck Pharmaceutical ETF declares quarterly distribution of $0.5328April 1, 2024 | msn.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328March 7, 2024 | investorplace.comThe Top 3 ETFs to Buy in March 2024February 28, 2024 | markets.businessinsider.com11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher YieldsFebruary 28, 2024 | stocknews.comNavigate to Success With These 4 Pharma Stocks to BuySee More Headlines Receive PPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Pharmaceutical ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:PPH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A Phone14089961010Fund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$611.31 million Average Daily Volume$143,788.70 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerIMC Options OptionableOptionable Options Volume22 Put Options1 Call Options22 Short Interest1,160,000 shs Miscellaneous Outstanding Shares5,940,000Beta0.72 Creation Unit50,000 Creation Fee$500.00 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. VanEck Pharmaceutical ETF ExpensesTypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.35%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.54%-0.21%-0.56%Net Expense0.35%0.60%0.60%0.54%0.58% VanEck Pharmaceutical ETF (PPH) Holdings & ExposureTop 10 PPH HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 12.28%Novo Nordisk A/S(NYSE:NVO)Holding Weight: 10.00%Johnson & Johnson(NYSE:JNJ)Holding Weight: 6.34%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 6.22%AstraZeneca(NASDAQ:AZN)Holding Weight: 5.95%AbbVie(NYSE:ABBV)Holding Weight: 5.30%Novartis(NYSE:NVS)Holding Weight: 4.94%McKesson(NYSE:MCK)Holding Weight: 4.75%GSK(NYSE:GSK)Holding Weight: 4.74%Pfizer(NYSE:PFE)Holding Weight: 4.72%PPH Sector ExposurePPH Industry ExposureFull Holdings Details Similar ETFsVanEck Biotech ETFNASDAQ:BBHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQInstitutional OwnershipCetera Investment AdvisersBought 19,912 shares on 5/24/2024Ownership: 0.441%Cetera Advisors LLCBought 6,682 shares on 5/24/2024Ownership: 0.112%Comerica BankBought 378 shares on 5/17/2024Ownership: 0.023%Beck Capital Management LLCBought 897 shares on 5/15/2024Ownership: 0.353%Axxcess Wealth Management LLCSold 1,394 shares on 5/14/2024Ownership: 0.172%View All Institutional Transactions PPH ETF - Frequently Asked Questions How have PPH shares performed in 2024? VanEck Pharmaceutical ETF's stock was trading at $81.37 at the start of the year. Since then, PPH shares have increased by 13.4% and is now trading at $92.25. View the best growth stocks for 2024 here. Are investors shorting VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF saw a decline in short interest in May. As of May 15th, there was short interest totaling 1,160,000 shares, a decline of 19.4% from the April 30th total of 1,440,000 shares. Based on an average daily trading volume, of 141,700 shares, the short-interest ratio is presently 8.2 days. View VanEck Pharmaceutical ETF's Short Interest. How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF announced a dividend on Thursday, March 28th. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.5328 per share on Friday, April 5th. The ex-dividend date is Monday, April 1st. Read our dividend analysis for PPH. What does PPH invest in? VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $611.31 million assets under management. What stocks does VanEck Pharmaceutical ETF hold? PPH invests in 26 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY), Novo Nordisk A/S (NVO), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AstraZeneca (AZN), AbbVie (ABBV), Novartis (NVS), McKesson (MCK), GSK (GSK) and Pfizer (PFE). What is the management fee for VanEck Pharmaceutical ETF? VanEck Pharmaceutical ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for PPH is 0.35%. What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO? 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of VanEck Pharmaceutical ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK), Applied Materials (AMAT), Applied Graphene Materials (AGM), Air Canada (AC) and Abbott Laboratories (ABT). Who are VanEck Pharmaceutical ETF's major shareholders? VanEck Pharmaceutical ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Avalon Trust Co (4.80%), J.Safra Asset Management Corp (1.17%), Orion Portfolio Solutions LLC (0.56%), Kingsview Wealth Management LLC (0.51%), Cetera Investment Advisers (0.44%) and Commonwealth Equity Services LLC (0.37%). How do I buy shares of VanEck Pharmaceutical ETF? Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PPH) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.